🔗 Permalink

Inventor profile of:

Stefan Klostermann

City:

Neuried

Country:

Germany

Published Applications:

Last publication date:

2026-04-09

Top Assignees for applications by Stefan Klostermann

The entities that hold a legal rights for patent applications filed by inventor Klostermann Stefan:

HOFFMANN-LA ROCHE INC. 25 Little Falls, NJ United States
Hoffmann-La Roche Inc. 2 Nutley, NJ United States
ENGMAB AG 1 Wilen, Switzerland
BRISTOL-MYERS SQUIBB COMPANY 1 Princeton, NJ United States
Hoffman-La Roche Inc. 1 Little Falls, NJ United States
ENGMAB AG 1 Pfäffikon, Switzerland

Recent patent applications by Klostermann Stefan

Stefan Klostermann from Neuried, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-09

US20260098095A1

Chemistry; metallurgy

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

#2 | 2026-01-22

US20260022172A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#3 | 2025-08-21

US20250263778A1

Chemistry; metallurgy

Method for discovery of alternative antigen specific antibody variants

#4 | 2025-04-24

US20250129179A1

Chemistry; metallurgy

ANTIBODIES BINDING TO HLA-A2/WT1

#5 | 2024-11-21

US20240383987A1

Chemistry; metallurgy

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

#6 | 2024-05-02

US20240141044A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#7 | 2023-09-14

US20230287118A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#8 | 2023-03-02

US20230068801A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#9 | 2022-12-29

US20220411534A1

Chemistry; metallurgy

Antibodies binding to HLA-A2/WT1

#10 | 2022-12-22

US20220403027A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#11 | 2022-07-14

US20220220500A1

Chemistry; metallurgy

METHOD FOR THE PRODUCTION OF AN ANTIBODY

#12 | 2021-10-07

US20210309730A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#13 | 2021-07-29

US20210230278A1

Chemistry; metallurgy

Antibodies binding to HLA-A2/MAGE-A4

#14 | 2021-03-11

US20210070882A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#15 | 2020-11-05

US20200347147A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#16 | 2020-07-23

US20200231673A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#17 | 2020-07-16

US20200223945A1

Chemistry; metallurgy

Three-dimensional structure-based humanization method

#18 | 2020-07-09

US20200216880A1

Chemistry; metallurgy

Method for discovery of alternative antigen specific antibody variants

#19 | 2020-02-27

US20200066372A1

Physics

METHOD FOR IMPROVING ANTIBODY STABILITY

#20 | 2018-10-04

US20180282410A1

Chemistry; metallurgy

ANTI-CD3XROB04 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#21 | 2018-08-09

US20180222981A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#22 | 2018-08-09

US20180222980A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#23 | 2018-04-12

US20180100006A1

Chemistry; metallurgy

METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS

#24 | 2017-12-07

US20170349669A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#25 | 2017-10-26

US20170306044A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER

#26 | 2017-10-26

US20170306036A1

Chemistry; metallurgy

Bispecific antibodies against CD3ϵ and BCMA

#27 | 2017-10-26

US20170306018A1

Chemistry; metallurgy

Bispecific antibodies against CD3EPSILON and ROR1

#28 | 2017-07-06

US20170190783A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#29 | 2017-06-22

US20170174786A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#30 | 2016-09-22

US20160275238A1

Physics

Method for improving antibody stability

#31 | 2016-03-17

US20160075785A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#32 | 2016-03-10

US20160068602A1

Chemistry; metallurgy

Sequence dependent aggregation

#33 | 2015-11-12

US20150323543A1

Physics

Anti-human IgG1 antibody

#34 | 2015-11-05

US20150315296A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#35 | 2015-09-03

US20150246961A1

Chemistry; metallurgy

METHOD FOR THE EXPRESSION OF POLYPEPTIDES USING MODIFIED NUCLEIC ACIDS

#36 | 2014-02-06

US20140038210A1

Physics

ANTI-HUMAN IgG1 ANTIBODY

#37 | 2013-03-14

US20130065277A1

Chemistry; metallurgy

Sequence dependent aggregation

#38 | 2012-08-16

US20120208216A1

Chemistry; metallurgy

Non-cross-reactive anti IgG antibodies

InventorID:

139745 ⎘